The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Open accessAbstract
BACKGROUND: Aldosterone plays a detrimental role on the cardiovascular system and PA patients display a higher risk of events compared with EH. OBJECTIVES: The objectives of the study were to compare cardio- and cerebrovascular events in patients with primary aldosteronism (PA) and matched essential hypertension (EH). METHODS: We retrospectively compared the percentage of patients experiencing events at baseline and during a median follow-up of 12 years in 270 PA patients case-control matched 1:3 with EH patients and in PA subtypes [aldosterone-producing adenoma (n = 57); bilateral adrenal hyperplasia (n = 213)] vs matched EH. RESULTS: A significantly higher number of PA patients experienced cardiovascular events over the entire period of the study (22.6% vs 12.7%, P < .001). At the diagnosis of PA, a higher number of patients had experienced total events (14.1% vs 8.4% EH, P = .007); furthermore, during the follow-up period, PA patients had a higher rate of events (8.5% vs 4.3% EH, P = .008). In particular, stroke and arrhythmias were more frequent in PA patients. During the follow-up, a higher percentage of PA patients developed type 2 diabetes. Parameters that were independently associated with the occurrence of all events were age, duration of hypertension, systolic blood pressure, presence of diabetes mellitus, and PA diagnosis. After division into PA subtypes, patients with either aldosterone-producing adenoma or bilateral adrenal hyperplasia displayed a higher rate of events compared with the matched EH patients. CONCLUSIONS: This study demonstrates in a large population of patients the pathogenetic role of aldosterone excess in the cardiovascular system and thus the importance of early diagnosis and targeted PA treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565
Savard, S., Amar, L., Plouin, P.-F., & Steichen, O. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01060 · Cited by 505
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351
Conditional Mineralocorticoid Receptor Expression in the Heart Leads to Life-Threatening Arrhythmias
Ouvrard-Pascaud, A., Sainte-Marie, Y., Bénitah, J.-P., Perrier, R., Soukaseum, C., Cat, A. N. D., Royer, A., Le Quang, K., Charpentier, F., Demolombe, S., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.503706 · Cited by 272
Born-Frontsberg, E., Reincke, M., Rump, L. C., Hahner, S., Diederich, S., Lorenz, R., Allolio, B., Seufert, J., Schirpenbach, C., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2116 · Cited by 261
The Pathophysiology of Aldosterone in the Cardiovascular System
ROCHA, R., & FUNDER, J. W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04415.x · Cited by 261
Apolipoproteins and ischaemic heart disease: implications for screening
Wald, N., Watt, H., Bailey, A., Johnson, M., Ledue, T. B., & Haddow, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90814-1 · Cited by 241
Pathophysiological effects of aldosterone in cardiovascular tissues
Rocha, R., & Stier, C. T. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00432-5 · Cited by 212
Aldosterone promotes atrial fibrillation
Reil, J.-C., Hohl, M., Selejan, S., Lipp, P., Drautz, F., Kazakow, A., Münz, B. M., Müller, P., Steendijk, P., Reil, G.-H., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr266 · Cited by 197
Comparison of Confirmatory Tests for the Diagnosis of Primary Aldosteronism
Mulatero, P., Milan, A., Fallo, F., Regolisti, G., Pizzolo, F., Fardella, C., Mosso, L., Marafetti, L., Veglio, F., & Maccario, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0078 · Cited by 195
Self-citationMineralocorticoid receptors in vascular function and disease
McCurley, A., & Jaffe, I. Z. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.014 · Cited by 178
Mulatero, P., Bertello, C., Rossato, D., Mengozzi, G., Milan, A., Garrone, C., Giraudo, G., Passarino, G., Garabello, D., Verhovez, A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2055 · Cited by 178
Self-citationMulatero, P., Bertello, C., Sukor, N., Gordon, R. D., Rossato, D., Daunt, N., Leggett, D., Mengozzi, G., Veglio, F., & Stowasser, M. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.146613 · Cited by 155
Self-citationAldosterone, mineralocorticoid receptor, and heart failure
Messaoudi, S., Azibani, F., Delcayre, C., & Jaisser, F. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.038 · Cited by 141
Role of KCNJ5 in familial and sporadic primary aldosteronism
Mulatero, P., Monticone, S., Rainey, W. E., Veglio, F., & Williams, T. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.230 · Cited by 133
Self-citationIs Primary Aldosteronism Associated with Diabetes Mellitus? Results of the German Conn's Registry
Reincke, M., Meisinger, C., Holle, R., Quinkler, M. O., Hahner, S., Beuschlein, F., Bidlingmaier, M., Seißler, J., & Endres, S. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246189 · Cited by 109
Aldosterone and the Cardiovascular System: Genomic and Nongenomic Effects
Funder, J. W. (2006) · Endocrinology · doi:10.1210/en.2006-0826 · Cited by 94
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis
Young, M. J., & Rickard, A. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.008 · Cited by 77
Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction
Leibovitz, E., Ebrahimian, T., Paradis, P., & Schiffrin, E. L. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328330a963 · Cited by 66
Aldosterone and the Heart: From Basic Research to Clinical Evidence
Catena, C., Colussi, G., Marzano, L. A., & Sechi, L. A. (2011) · Hormone and Metabolic Research · doi:10.1055/s-0031-1291318 · Cited by 64
Differential diagnosis of primary aldosteronism subtypes
Mulatero, P., Bertello, C., Verhovez, A., Rossato, D., Giraudo, G., Mengozzi, G., Limerutti, G., Avenatti, E., Tizzani, D., & Veglio, F. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0038-1 · Cited by 47
Self-citationMineralocorticoid Receptor Blockade in the Protection of Target Organ Damage
Mulatero, P., Milan, A., Williams, T. A., & Veglio, F. (2006) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152506775268776 · Cited by 43
Self-citationGenetics of primary aldosteronism
Mulatero, P., Morello, F., & Veglio, F. (2004) · Journal of Hypertension · doi:10.1097/00004872-200404000-00001 · Cited by 36
Self-citationThree-year follow-up of Mini-Mental State Examination score in community residents aged 85 and over
Izaks, G. J., Gussekloo, J., Dermout, K. M. T., Heeren, T. J., & Ligthart, G. J. (1995) · Psychological Medicine · doi:10.1017/s0033291700035091 · Cited by 36
Genomic and Non-genomic Effects of Aldosterone
Verhovez, A., Williams, T. A., Monticone, S., Crudo, V. L., Burrello, J., Galmozzi, M. R., Covella, M., Veglio, F., & Mulatero, P. (2012) · Current Signal Transduction Therapy · doi:10.2174/157436212800376708 · Cited by 35
Self-citationQT interval in patients with primary aldosteronism and low-renin essential hypertension
Maule, S., Mulatero, P., Milan, A., Leotta, G., Caserta, M., Bertello, C., Rabbia, F., & Veglio, F. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000251908.93298.a0 · Cited by 30
Self-citationGenes implicated in insulin resistance are down-regulated in primary aldosteronism patients
Williams, T. A., Monticone, S., Urbanet, R., Bertello, C., Giraudo, G., Vettor, R., Fallo, F., Veglio, F., & Mulatero, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.007 · Cited by 25
Self-citationAldosterone and Risk for Insulin Resistance
Whaley‐Connell, A. T., & Sowers, J. R. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.182782 · Cited by 16
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Self-citationWilliams, T. A., Lenders, J. W. M., Mulatero, P., Burrello, J., Rottenkolber, M., Adolf, C., Satoh, F., Amar, L., Quinkler, M., Deinum, J., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30135-3 · Cited by 969
Self-citation
Metadata
- Authors
- Mulatero, P., Monticone, S., Bertello, C., Viola, A., Tizzani, D., Iannaccone, A., Crudo, V., Burrello, J., Milan, A., Rabbia, F., & Veglio, F.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-12
- Volume
- 98
- Issue
- 12
- Pages
- 4826-4833
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2136936562
- Cited by
- 415
- References
- 29
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.